"IFN-Lipint": hōʻike manaʻo, ke aʻo, analogs, noi, kuai

O ia hoʻi, "IFN-Lipint" mea he antiviral lāʻau i ua ua hana ma ke kulanui i nā kānaka interferon. I ka haku mele 'ana o kēia hoʻomanaʻo nō maloʻo recombinant Alpha-2 kanaka interferon-Hoʻokolohua. I ka lāʻau, e like 'ē ai', a me nā hale i loaʻa o keia hui ka paipai 'ana i ke kanaka i ka iho'ōnaehana paleʻea kahua. Noi mai o kēia mau medicaments ua lawe mai ma kela infectious lesions ka wā hoʻonāwaliwaliʻia iho ola. No ka laʻana, i loko o ka papa o ka immunotherapy, systemic maʻi.

"IFN-Lipint" ua hoʻohana 'ia:

• I ka lawe ana mai i ke ahulau o SARS Kāohiʻana.
• D. Ma ka hihia o systemic maʻi, e like me atopic dermatitis, asthma a me ka mea e like.
• I mea hoʻomaʻi hepatitis B - i loko o nā huʻi a me ka maʻi.

"IFN-eu Lipint" 'ano ma ka pauka palapala. I ka hue ua hou koke mamua e ke hoʻohana i puhi ia paha hoolapalapaia i ka wai, a laila, pau vigorously naueue. E like me na kuhikuhi, ka lāʻau ua? Aeiiaiaoaony e lawe hapalua o ka hola muaʻai. Eia naʻe iho noi noaia ua hōʻike hewa no kēlā me kēia hoomanawanui, ke kauka ua koiia e pena au mamuli. E like me ka rula, o ka huina o na papa o ka lapaʻau mea i oi aku mamua o hookahi mahina.

Na ano o ke kalaʻana aku, uku

• He lepo lā lyophilized 500.000 Iu / ml (Ku una Ha) - kumu keia i kuai 700 rubles.
• E hoomakaukau ai i ka lyophilized lepo slurry 1.000.000 Iu (Ku una Ha) - kumukuai o ma kahi o 1000 rubles.
• E hoomakaukau ai i ka wehe i ka lyophilised lepo 250.000 Iu (Ku una Ha) - kumukuai ma kahi o 410 rubles.

"IFN-Lipint": counterparts

Kēia lāʻau i ke kēia analogues:

• "Infagel".
• "Viferon-mea poni".
• "Viferon".

nāʻikepili

Lyophilized ka pauka 1 Iu miliona a me 250 000 Iu no na hana ua waiho ia ma ka kēia hihia.

• Lapaau a me ka Kāohiʻana o ka huʻi mea hoʻomaʻi naehana nā mea palahēhē a me ka maʻi palū.
• Mau sclerosis.
• Kaposi ka sarcoma pili i kōkua iā ia,.
• Clasmocytoma.
• Granulosarcoid.
• hakuʻala Ka maʻi 'aʻai.
• Mau myeloma.
• Hoʻololi palapala granulocytic maʻi leukemia a me ka myelofibrosis.
• N me ka haumāna thrombocytosis.
• ʻeleu mea hoʻomaʻi hepatitis C.
• Myeloid leukemia i loko o ka maʻi palapala.
• Huluhulu aeea leukemia.

He lepo lā lyophilized 500.000 Iu / ml "IFN-Lipint" me he mea poni i hoʻohana 'ia ma ka mea hoʻomaʻi lesion mucous membranes a me integuments o kekahi IIeEeAIEUAA.

Kaʻeleu ano o ka suppository hoʻomanaʻo ua hoʻohana 'ia ma ka hui pu ana, Inc me ka maʻi puʻuwai like:

• Infectious-hoʻoʻino maʻi o na keiki, a me premature a me keiki keiki.
• Meningitis.
• Sepsis.
• Maʻi palū, SARS, a me mea koʻohune maʻiʻaʻai complications.
• Chlamydia, mea hoʻomaʻi a me ka mea koʻohune pneumonia.
• Intrauterine maʻiʻaʻai - enterovirus maʻiʻaʻai, CMV maʻiʻaʻai, herpes, chlamydia, candidiasis, me visceral mycoplasmosis.
• Mea hoʻomaʻi maʻi hepatitis B, C, D i loko o nā mākua a me nā keiki, a me ka hoʻohui pū hemosorption a me ka plasmapheresis mea hoʻomaʻi maʻi hepatitis me ka ake cirrhosis a me ke koʻikoʻi loa o ka ha awina.

E like me ka interferon-ee a 'o ia hoʻi "IFN-Lipint" (kumukuai i haawiia mai ma luna) ua hoʻohana' ia ma ka hihia o na kēia mau maʻi:

• Urogenital maʻiʻaʻai (kanaka papillomavirus maʻiʻaʻai, mycoplasmosis, vaginal recurrent candidiasis, mea koʻohune vaginosis, trichomoniasis, ureaplasmosis, mea koʻohune vaginosis, CMV maʻiʻaʻai, chlamydia).
• Recurrent a iniiaiie maʻiʻaʻai o ka mucosa a me ka ili.
• Maʻi palū a me nā huʻi naehana nā mea palahēhē a me ODS, a me complications i loko o nā mākua mea koʻohune maʻiʻaʻai.

Contraindications

Uluwehi O "IFN-Lipint" (ke kumukuai hilinaʻi nui ma luna o ke kalaʻana aku palapala) i ka i kēia contraindications:

• Hihia hoʻi hakuʻala hana, ake ole circulatory kahua.
• Hypersensitivity.
• Maʻi hepatitis i loko o nā mea maʻi i loaa koke ma mua immunosuppressive Inc (me ke koe o ka pōkole-manawa mālama '-lapaʻau me steroid).
• Myocardial infarction.
• Maʻi hepatitis kena ae la decompensated ake cirrhosis.
• Loa naau maʻi (me mōʻaukala).
• Epilepsy 'ole' ē aʻe Central ko mākou hopohopo kahua kāna hana.

Eia hou kekahi, "IFN-Lipint" (. Reviews o ka la hoomalolo,ʻike ma lalo nei), ua kekahi mau hoʻokau 'ia ka hoʻohana' ana o ka:

• High pā lonoaʻili i ka hoʻopā ai o ka lāʻau eiiiiiaiou.
• Breastfeeding.
• Hāpai keiki.

ʻaoʻao waiwai

Lyophilized pauka no ku una 1.000.000 Iu a me 250 000 Iu "IFN-eu Lipint" (ke kumukuai hilinaʻi nui ma luna o ke kinona o ke kalaʻana aku) i ka kēiaʻaoʻao ole:

• Allergic ili reactions (e laʻa me, maneo a me hives).
• hiamoe o na kanaka haunaele.
• Nervousness.
• Hoʻopōʻino ike paka i.
• Drowsiness.
• Kaumaha.
• Ischemic retinopathy.
• Ke kākoʻo ka haunaele.
• Pōniuniu.
• Hepatitis.
• 'āno'ē ake kuleana pili i.
• Heartburn.
• Mahuahua peristalsis.
• Flatulence.
• Constipation.
• Abdominal eha.
• Ole a me ka wela
• Diarrhea.
• Weight me keia poho.
• Maloo waha.
• Hoʻololi i kaʻai.
• Ka luaʻi, a nausea.
• Sweating.
• Pain i loko o na ami.
• Headache a Muscle eha.
• Ilihune kona'ōpū.
• Lethargy.

"IFN-Lipint" lyophilized pauka na keiki 500 000 Iu / ml:

• Hamo Cuticura -ʻaoʻao 'ole i ua kaulana.
• Suppositories - kākaʻikahi hoikeia allergic naoh (e laʻa me, maneo a me ka poʻe noʻonoʻoʻole).

AaOIeIOUIeXAOAaIN

Interferon Alpha ho'ēmi i kā ka ha awina o ka cytochrome P-450, i loli ai ka pūnao o warfarin, propranolol, diazepam, theophylline, chimes, phenytoin cimetidine a me kekahi cytotoxic ai '. A e mahuahua cardiotoxicity, neurotoxicity a myelotoxic 'ole o ka ai', a ua hoʻomaka e lawe ka poʻe me ka 'ole mamua.

Eia hou, i ka pono, e pale aku concomitant aaieieno? "IFN-eu Lipint" (i ke kumu kuai i hoikeia ma luna) me ka ai 'i he hoʻonui ai i ka luhi o ka Central ko mākou hopohopo'ōnaehana, e like me immunosuppressive ai' (me parenteral a me ka moʻolelo ano o corticosteroids).

Ua Ua ikaika papaia ma ka iapaau ana, e lawe ka waiʻona.

hiki mahele lāʻau

Ka lāʻau 'Ua lawe hapalua o ka hora mua, inu o ka ai. No ka mea Kāohiʻana o SARS a me ka maʻi palū - 1 mea hōʻikeʻikeʻuʻuku (500 000 Iu) kekahi lā oiai o ka mahina, 2 manawa i ka pule. I ka lapaau ana o SARS a me ka maʻi palū - 1 mea hōʻikeʻikeʻuʻuku (500 000 Iu) kela la i keia no 5 mau lā, 2 manawa i ka lā. I ka paakiki moni 'ia i ke akahele wehe i ka mea hōʻikeʻikeʻuʻuku, a lawe i nā mea me ka uuku nui o ka wai.

Dosing a me ka noho kia'āina '

Kēia medicament ua lawelawe hōʻike waha. Prior i kona pololei noi ana i kahi o ka hue i pākuʻi anuanu hoolapalapaia paha i puhi ia i ka wai (1.2 ml). E like me ka hopena, e pili ana i 1-5 minuke, luliluli he homogeneous nui e hōʻike.

1. Ma ka hihia o ka huʻi hepatitis medicament ua ia 30 minuke mamua i ka hokii, o ka ai ma ka kēia noaia:

• Children mai 3 a hiki i 7 makahiki - ka lāʻau ua ia 10 lā, 1 manawa no ka lā 500 000 Iu. Ma hope o biochemical haʻawina o ke koko ho'āʻo "IFN-Lipint" no na keiki (kumukuai hilinaʻi nui ma luna o ke kalaʻana aku palapala) ua hoʻohana 'ia no kekahi manawa hou - ma mua o ka hoouka kaua ana o piha lapaʻau ke ola.
• Children mua ma mua 7 makahiki o ka makahiki, a me nā mākua - 10 lā 2 manawa i ka lā, 1 miliona Iu.

2. Ma ka hihia o ka maʻi hepatitis B i loko o ka replicative pepa (ʻeleu a AEeOEXAaI), a me maʻi hepatitis B, pili me ka glomerulonephritis, e e lawe i ka lāʻau 30 minuke ma mua ka lawe ai, penei:

• Children mai 3 a hiki i 7 makahiki o ka makahiki e lawe i kēia ka lapaʻauʻia 10 lā, 2 manawa i ka lā me 500 000 iaia, a laila, - no 1 malama 1 manawa no ka lā (kaʻoi loa i ka po,) i ka lā, 500 000 Iu.
• Children mua ma mua 7 makahiki o ka makahiki, a me nā mākua - 10 lā 2 manawa i ka lā, 1 miliona Iu, alaila, no 1 malama 1 manawa no ka lā (ma ka po,) i ka lā.

3. Ma ka hanana o ka kekahi Inc, pono e hoʻohana ' "IFN-Lipint" (manaʻo ma lalo nei) i loko o 30 minuke ma hope o kaʻai i loko o ke kakahiaka hora like penei:

• Ma ka hihia o atopic asthma mākua - no 10 mau lā ma luna o kekahi i kela la 'aelike 500 000 Iu. A laila, i loko o 20 mau lā ma hope o ka lā ma luna o 500.000 Iu. Ka huina lōʻihi like 'ole, he 30 lā.
• Ma ka hihia o allergic rhinoconjunctivitis - no 10 mau lā ma luna o kekahi i kela la 'aelike 500 000 Iu.

4. No ka mea o ka Kāohiʻana a me ka hana o ka huʻi naehana nā mea palahēhē a me ka maʻi palū keia ka lapaʻauʻia ua lawe hapalua o ka hola muaʻai. "IFN-Lipint" a hiki i ka hoʻohana 'ana i ke aʻo ua hookupaa iho la ia, oe e inu like penei:

• Ma ka iapaau ana o ka huʻi naehana nā mea palahēhē a me ka maʻi palū - i loko o 3 mau lā kela la i keia 2 manawa i ka lā me 500 000 Iu.
• Me ka manao o ka Kāohiʻana o ARI a maʻi palū - me ke ala o ka morbidity lawe ka lapaʻauʻia no 1 mahina 2 manawa no hebedoma 1 manawa no ka lā 500 000 Iu.

overdose

Hihia nui loa i ka laʻau heluna o ka lāʻau i malama. Paha wale he mahuahua ma ka mahele lāʻau-piliʻaoʻao ole. Overdose nae symptomatic lapaau.

like inoa

"Eberon Alpha P", "IFN-eu Lipint" no na keiki "Realdiron", "ALFARON", "Layfferon", "Intron-A."

na Agena

Ka lāʻau 'E kaʻoi loa e waiho mai o ka loaa ole ana o na keiki uuku, palekana mai Map wahi. Pela pūnaewele mahana e ole oi 8 ° C.

kekahi koi

Ka lāʻau,ʻaʻole ia i ka hiki i ka pāʻana palena papaha mea hana a me ka kaa. Inā e 'ike allergic reactions e imi koke' inikua noonoo.

me kuu

"IFN-Lipint" no na keiki (kūmole ma lalo nei) ua hookuu wale me ka kuhikuhi mai i ke kauka.

nā'ana hoʻomalu

Kēia lāʻau 'ka poʻe i loaa ole wale anticancer a me ka antiviral haʻawina, akā, i ka hiki i ka'ōnaehana paleʻea'ōnaehana e hoʻihoʻi aku. Kona laha ana ka mea ua loaa ia no ka hana maikaʻiʻole o ka mea hoʻomaʻi hepatitis B, e like nā antiviral ai 'ma mua o mua oia i kauoha mai ai, no laila, nolaila, nui ka manaolana o antiviral hopena. 5 mau lā ma hope o ka jaundice maʻiʻo ia i kauoha hou.

Eia hou, ua hoʻohana 'ia k ‰ ia ma ka hihia o ka mea hoʻomaʻi meningoencephalitis, akā, wale no ka eha lā mua o ka maʻi. Kekahi "IFN-Lipint" 'Imi hoʻohana no ka mea hoʻomaʻi conjunctivitis a me ka keratitis. Antitumor ha awina apono 'oe e hāʻawi aku i kēia i loko o k ‰ kekahi mauʻano likeʻole o ka maʻi' aʻai, o ka oi aku i ka maʻi 'aʻai koko. Maikaʻi loa i nā hualoaʻa i ua loaa ma ka iapaau ana o mau sclerosis.

A uaʻike i kekahi waeʻano o nā mea maʻi me poorly tolerated i ka hana o keia k: he mea luhi, nawaliwali, kuni, ole. Naʻe, hoʻowahāwahā i kēia, i ke ala o ka lapaʻau, i loko o ka hapanui manawa, pono e hoʻomau.

I kekahi manawa, i ka iapaau ana mea he pahikakiwi oi emi i loko o ke koko platelets a me leukocytes, i pono ai ka hooponopono ana o ke koko Ka Ikepili a me ka lapaʻau loina (ma kahi o 2-3 manawa iloko o ka hebedoma). I loko nō o kaʻaoʻao waiwai, e like me ka rula, ka koke withdrawal o ka lāʻau ua eliminated, mai E e lawe wale i ka abolition o kona olelo hooholo me ka hoʻomalu, ua hoonohoia "IFN-eu Lipint". O ke kumu ho i ka mea i ke kakali ana i pomaikai ana me neia i ka olelo hooholo, e hoopau i ka pono, e noonoo, a me ka loa 'O ke kaulike hele.

pono

• Ma ka naau o keia k mea? Iie? Acaeoey, i i i hookoia ai ka Lūkini Aupuni uku.
• Ke hoʻohālikelike a me nā ai ', e e lawe "IFN" ma ka waha (hōʻike waha'). Kēia ololi mea nui oi loa aku hoi i loko o pediatrics.
• Liposomal interferon mea hemolele no ka pilikia Kāohiʻana o SARS a me ka maʻi palū, i ka wa i hui 'ana me ka mea hoʻomaʻi, akā, e mai i na symptoms o ka maʻi a eia wale māhunehune kekahi'.
• Liposomes paipai hooloihi ae i holo i loko o ke koko interferon.
• "IFN" hana me ka inductor, i mea, e ka poʻea pau i ka ulu ana o kona iho interferon.

Ua makaukau ka loaʻa o ka recombinant interferon, i? Ac? E aaiaoe 'enekinia,ʻano hana i loko o lūmaua. Ma nā hua'ōlelo, keia k mea,ʻaʻole he kumu koko huahana a me ka mea hiki ole ke kakauiaʻi maluna hoʻopōʻino maʻiʻaʻai.

Cautions

I hōʻike muaʻia aʻe, i loko o ka papa o ka lawe i kēia lapaau, e pale aku kona hui pu ana, me ka immunosuppressants, e like me na laau e hiki i kekahi kanawai i ka CNS. Ma ka ihu i mea nui e kanaka hoʻoponopono i ka hana o ke ake, a me ke koko hana hehee wale. Ia i kekahi mau mea alleviate maʻi palū-e like symptoms (ʻaoʻao 'ole), kaʻoi loa ka poʻe me ka? Eaia o keia hoʻomākaukau hāʻawi aku paracetamol.